Cancer treatment may lead to bone loss
Wednesday, 19 November 2008 - A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year and...
Edited by: JV
New FDA approved at-home immunodiagnostic test for detecting low concentrations of sperm
Wednesday, 19 November 2008 - In a report now available online and scheduled to be the cover story of the December 2008 issue of the Journal of Urology, University of Virginia Health System researcher John C. Herr, PhD and his colleagues have confirmed the accuracy and reliability of SpermCheck Vasectomy, the first...
Edited by: FGR
Finnish researchers provide new data on CA IX study
Tuesday, 18 November 2008 - Carbonic anhydrase IX (CA IX) is an exceptional member of the CA protein family. Besides its classical role in pH regulation, CA IX has also been proposed to participate in cell proliferation, cell adhesion, and tumourigenic processes.
“To characterise the biochemical properties of...
Edited by: JV
Erectile dysfunction management for the future
Monday, 17 November 2008 - The field of erectile dysfunction (ED) management over time has witnessed assorted interventions to enable the male to perform sexual intercourse. In recent times, major progress in ED research has led to increasingly effective treatments based on a refined knowledge of the scientific basis...
Author: Burnett
Role of androgens in penile tissue architecture and erection
Monday, 17 November 2008 - Androgens are essential for development, growth and maintenance of penile structure and regulate erectile physiology by multiple mechanisms. In a review, Traish (2008) provided a concise overview of the basic research findings pertaining to androgen modulation of erectile tissue architecture...
Author: Traish
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
Sunday, 16 November 2008 - The proof of principle that a drug targeting mTOR (The mammalian target of rapamycin is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription) can improve survival is obtained recently from a large...
Authors: Le Tourneau et al.
An update on the laparoscopic approach to urogynecology and pelvic reconstructive procedures
Sunday, 16 November 2008 - Advances in minimally invasive surgery have led to the increasing adoption of laparoscopic techniques in urogynecology and reconstructive pelvic surgery. Diwadkar et al. (2008) reviewed the evidence behind laparoscopic pelvic organ prolapse and urinary incontinence repair.
A review of...
Authors: Diwadkar et al.
Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma
Saturday, 15 November 2008 - By using contrast-enhanced CT or MRI as the reference imaging technique, Meloni et al. (2008) assessed the diagnostic performance of low-mechanical-index contrast-enhanced sonography in detecting local tumor progression after percutaneous radiofrequency ablation of renal...
Authors: Meloni et al.
Effect of nerve-sparing technique or potency on continence after open radical retropubic prostatectomy
Saturday, 15 November 2008 - Marien and Lepor (2008) characterized the effect of preserving the neurovascular bundle (NVB) and of potency on urinary continence after open radical retropubic prostatectomy (ORRP).
Between October 2000 to September 2005, 1110 consecutive continent men had ORRP. The University of...
Authors: Marien et al.
Coffee consumption, genetic susceptibility and bladder cancer risk
Friday, 14 November 2008 - Coffee is a complex mixture of chemicals. The carcinogenic potential of coffee has been examined in animal studies with inconsistent results. Villanueva et al. (2008) evaluated the bladder cancer risk associated with coffee consumption in a case-control study in Spain and examined the...
Authors: Villanueva et al.
